683 Capital Management’s Biote Corp. Warrant BTMDW Stock Holding History

683 Capital Management’s Portfolio BTMDW Stock Details BTMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-59,642	Closed	-$33K	–	351
2022 Q1	$33K	Hold	59,642	–	–	﹤0.01%	316
2021 Q4	$43K	Hold	59,642	–	–	﹤0.01%	324
2021 Q3	$48K	Hold	59,642	–	–	﹤0.01%	202
2021 Q2	$63K	Buy	+59,642	New	+$51.6K	﹤0.01%	191

Other funds holding BTMDW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

SRF

Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

683 Capital Management's BTMDW Position: Q2 2022 in Review

683 Capital Management sold out of Biote Corp. Warrant (BTMDW) in Q2 2022, closing a stake of 59,642 shares — an estimated $33K sold.

683 Capital Management first reported a position in BTMDW in Q2 2021 and held it in 4 quarters. The position peaked at $63K in Q2 2021. 42 funds tracked by Wall St. Rank hold BTMDW as of Q2 2022.

683 Capital Management reported no remaining Biote Corp. Warrant position as of Q2 2022 after selling out during the quarter.
683 Capital Management sold 59,642 Biote Corp. Warrant shares in Q2 2022, an estimated $33K.
683 Capital Management first reported a position in Biote Corp. Warrant in Q2 2021 and held it in 4 quarters.
683 Capital Management's Biote Corp. Warrant position peaked at $63K in Q2 2021.
42 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q2 2022.

Based on 683 Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.